Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000408453

Medchemexpress LLC Ciclopirox (olamine) | 41621-49-2 | 99.8% | 50 MG
SDP

Catalog No. 5000408453
Encompass_Preferred

Ciclopirox olamine is a synthetic, orally active antifungal agent for superficial mycoses research. It exhibits a broad spectrum of activity against dermatophytes, yeasts, molds, and various Gram-positive and Gram-negative pathogenic species. This compound also demonstrates anticancer and anti-inflammatory effects.

  • Inhibits dermatophytes, yeasts, and molds
  • Active against Gram-positive and Gram-negative species
  • Shows anticancer activity in various cell lines and xenograft models
  • Exhibits anti-inflammatory effects
  • Inhibits HUVEC proliferation and angiogenesis
  • Induces cell aerobic glycolysis and impairs mitochondrial functions

Catalog No. 50-004-08453 Supplier Medchemexpress LLC Supplier No. HYB0450A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ciclopirox olamine is a synthetic, orally active antifungal agent for superficial mycoses research. It exhibits a broad spectrum of activity against dermatophytes, yeasts, molds, and various Gram-positive and Gram-negative pathogenic species. This compound also demonstrates anticancer and anti-inflammatory effects.

  • Inhibits dermatophytes, yeasts, and molds
  • Active against Gram-positive and Gram-negative species
  • Shows anticancer activity in various cell lines and xenograft models
  • Exhibits anti-inflammatory effects
  • Inhibits HUVEC proliferation and angiogenesis
  • Induces cell aerobic glycolysis and impairs mitochondrial functions

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.